MTB by GeneXpert – PUS Test in Karachi at Dr. Essa Lab

MTB by GeneXpert – PUS at Dr. Essa Lab

Extrapulmonary tuberculosis (EPTB) presents a significant diagnostic challenge in modern clinical medicine, particularly in highly endemic regions like Pakistan. Unlike pulmonary tuberculosis, which is primarily diagnosed through sputum examination, extrapulmonary manifestations often present as localized fluid collections, cold abscesses, or purulent discharge in deep tissues, lymph nodes, and joints. Diagnosing tuberculosis from these pus specimens has historically relied on conventional methods such as Acid-Fast Bacilli (AFB) smear microscopy and mycobacterial culture. However, smear microscopy suffers from extremely low sensitivity in paucibacillary extrapulmonary samples, while traditional culture on Lowenstein-Jensen (LJ) medium can take anywhere from four to eight weeks to yield definitive results. This prolonged turnaround time delays critical therapeutic intervention, potentially leading to irreversible tissue damage or systemic disease progression.

To address these diagnostic limitations, Dr. Essa Lab offers the advanced MTB by GeneXpert – PUS test at its state-of-the-art diagnostic centers in Karachi and across Pakistan. This revolutionary molecular assay utilizes real-time Polymerase Chain Reaction (PCR) technology to rapidly detect the DNA of the Mycobacterium tuberculosis complex (MTBC) directly from pus and aspirate specimens. Beyond mere detection, the GeneXpert platform simultaneously identifies mutations in the rpoB gene, which serve as a highly reliable surrogate marker for resistance to rifampicin, one of the most critical first-line anti-tuberculosis medications. By delivering highly sensitive, specific, and automated results within a matter of hours, this test empowers clinicians to make rapid, evidence-based decisions, initiate targeted anti-tubercular therapy (ATT), and effectively manage drug-resistant tuberculosis cases.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation and specimen collection are paramount to ensuring the accuracy and diagnostic yield of the MTB by GeneXpert – PUS test. Patients should observe the following guidelines prior to the procedure:

• Clinical Coordination: The collection of pus or purulent aspirate must be performed by a qualified healthcare professional, such as a surgeon, radiologist, or trained clinician, under strict aseptic conditions.
• No Dietary Restrictions: There is no requirement for fasting before this test. Patients may consume food and liquids normally.
• Medication History: It is essential to inform the clinical team if the patient is currently taking anti-tuberculosis therapy (ATT) or broad-spectrum antibiotics, as these can alter the bacterial load, though molecular testing can still detect DNA from non-viable bacilli.
• Aseptic Site Preparation: The skin overlying the abscess, lymph node, or joint must be thoroughly disinfected with an appropriate antiseptic solution (such as povidone-iodine or isopropyl alcohol) prior to aspiration to prevent contamination with skin flora.
• Sterile Collection Container: The specimen must be collected directly into a sterile, leak-proof container without any additives, preservatives, or saline, unless specifically instructed by the laboratory.

During the Procedure

The collection of a pus specimen is a clinical procedure that varies depending on the anatomical location of the suspected infection:

• Patient Positioning: The patient is positioned comfortably based on the site of the fluid collection. For example, a sitting position is common for cervical lymph node aspiration, while a recumbent position is used for deep tissue or spinal abscesses.
• Aspiration Process: A clinician performs a fine-needle aspiration (FNA) or an incision and drainage under sterile conditions. For deep-seated or non-palpable abscesses, ultrasound or computed tomography (CT) guidance may be employed to ensure precise needle placement and patient safety.
• Sample Transfer: The aspirated pus or purulent fluid is immediately transferred into a sterile container. A minimum volume of 1 to 2 milliliters is typically required for optimal molecular processing.
• Laboratory Processing: Upon arrival at Dr. Essa Lab, the specimen is treated with a specific liquefaction and homogenization buffer. This step breaks down the thick, viscous matrix of the pus, releasing the mycobacterial DNA.
• Cartridge Loading: The treated sample is pipetted into a single-use, self-contained GeneXpert cartridge, which is then loaded into the automated GeneXpert instrument.
• Automated PCR Run: The instrument automates all steps of the molecular process, including cell lysis, DNA extraction, genomic amplification, and real-time detection of target sequences using fluorescent probes. The entire automated run takes approximately two hours, and because the cartridge is completely sealed, the risk of cross-contamination or laboratory-acquired infection is virtually eliminated.

When is a MTB by GeneXpert – PUS Performed?

Suspected Tuberculous Lymphadenitis

Tuberculous lymphadenitis, particularly involving the cervical lymph nodes (historically known as scrofula), is one of the most common presentations of extrapulmonary tuberculosis. Patients typically present with chronic, painless, and progressively enlarging lymph nodes that may eventually undergo liquefactive necrosis, forming a fluctuant cold abscess. Clinicians request the MTB by GeneXpert – PUS test on the aspirated fluid to rapidly differentiate tuberculous lymphadenitis from pyogenic bacterial infections or malignant lymphadenopathy, allowing for prompt initiation of appropriate therapy.

Cold Abscesses and Deep Tissue Infections

Cold abscesses are localized collections of pus that lack the classic signs of acute inflammation, such as warmth, erythema, and severe pain. These abscesses are highly characteristic of tuberculous infections and can occur in various deep tissues, including the paraspinal and psoas muscles. Because these abscesses can mimic other chronic infectious or inflammatory processes, the GeneXpert assay is critical for identifying the presence of Mycobacterium tuberculosis DNA directly from the purulent aspirate, confirming the tuberculous etiology.

Osteoarticular Tuberculosis (Bone and Joint TB)

Tuberculosis of the bones and joints, including spinal tuberculosis (Pott’s disease), often leads to joint destruction, bone erosion, and the formation of cold abscesses or joint effusions. Synovial fluid or pus aspirated from the affected joint or paraspinal lesion is analyzed using the GeneXpert test. Rapid diagnosis is vital in these cases, as delayed treatment can lead to permanent neurological deficits, spinal deformity, or severe joint dysfunction.

Cutaneous Tuberculosis and Chronic Draining Sinuses

Cutaneous tuberculosis can present as chronic, non-healing ulcers, plaques, or scrofuloderma, which often develop draining sinus tracts that discharge purulent material. The MTB by GeneXpert – PUS test is performed on the purulent discharge to confirm the diagnosis of cutaneous TB, distinguishing it from other chronic dermatological conditions, fungal infections, or atypical mycobacterial diseases.

Evaluation of Drug-Resistant Tuberculosis (MDR-TB)

Pakistan has a high burden of multi-drug resistant tuberculosis (MDR-TB). When a patient with extrapulmonary symptoms fails to respond to standard empirical anti-tubercular therapy, or has a history of previous TB treatment, clinicians suspect drug resistance. The GeneXpert test is invaluable in these scenarios because it simultaneously detects rifampicin resistance mutations in the rpoB gene. Identifying resistance within hours enables specialists to immediately design an effective second-line treatment regimen, avoiding the weeks-long wait associated with conventional drug susceptibility testing.

What Does a MTB by GeneXpert – PUS Detect?

The MTB by GeneXpert – PUS test is a highly sophisticated molecular assay designed to detect several critical diagnostic parameters from a single pus specimen:

• Presence of Mycobacterium tuberculosis Complex (MTBC) DNA: Confirms the presence of the genetic material of the tuberculosis-causing bacteria.
• Absence of MTBC DNA: Indicates that tuberculosis DNA was not detected within the limits of the assay, suggesting an alternative diagnosis.
• Rifampicin Resistance Status: Detects mutations in the 81-bp rifampicin resistance-determining region (RRDR) of the rpoB gene.
• Rifampicin Sensitivity: Confirms the absence of detectable mutations in the rpoB gene, indicating likely susceptibility to first-line ATT.
• Indeterminate Rifampicin Resistance: Occurs when the bacterial DNA load is extremely low, preventing the clear determination of the resistance status.
• Very Low Bacterial Load: Quantifies the presence of MTBC DNA at a minimal level, demonstrating the high sensitivity of the PCR assay.
• Low Bacterial Load: Indicates a low but clearly detectable concentration of mycobacterial DNA in the specimen.
• Medium Bacterial Load: Reflects a moderate concentration of target DNA, correlating with a moderate bacterial burden.
• High Bacterial Load: Indicates a high concentration of mycobacterial DNA, suggesting an active, highly proliferative infection.
• Exclusion of Non-Tuberculous Mycobacteria (NTM): The assay specifically targets MTBC DNA, helping clinicians rule out infections caused by atypical mycobacteria.
• Specimen Validity: Utilizes an internal sample processing control (SPC) to ensure that the extraction and amplification steps occurred correctly.
• Presence of PCR Inhibitors: Identifies if substances within the pus (such as hemoglobin or mucin) have interfered with the enzymatic reaction, resulting in an invalid test.
• Instrument or Cartridge Errors: Detects technical anomalies during the run, prompting a repeat test to ensure accuracy.
• Paucibacillary Infection Detection: Successfully identifies TB in samples that would otherwise be reported as negative on routine AFB smear microscopy.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is committed to providing rapid and highly accurate diagnostic services to facilitate timely clinical decisions. For the MTB by GeneXpert – PUS test, results are typically available within 24 to 48 hours from the time the specimen is received at the laboratory. This rapid turnaround is essential for patients presenting with acute or severe extrapulmonary symptoms. Patients and referring physicians can easily access reports online through the secure Dr. Essa Lab web portal or via their dedicated mobile application. Additionally, automated SMS notifications are sent to patients as soon as their reports are finalized, ensuring seamless and convenient access to critical health information.

MTB by GeneXpert – PUS Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
MTBC DNA Detection	Not Detected	Detected (indicates active Mycobacterium tuberculosis complex infection)
Rifampicin Resistance	Not Detected (Sensitive)	Detected (indicates rpoB gene mutation / drug resistance)
Bacterial Load Quantification	None	Very Low, Low, Medium, or High
Sample Validity / SPC	Valid	Invalid / Error (requires sample recollection or retesting)
PCR Inhibitors	Absent	Present (interferes with DNA amplification, yielding invalid results)
Atypical Mycobacteria (NTM)	Not Detected	May require alternative PCR or culture (GeneXpert is specific to MTBC)
Clinical Correlation	No evidence of active tuberculosis	Active extrapulmonary tuberculosis (e.g., tuberculous abscess or lymphadenitis)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for MTB by GeneXpert – PUS?

• Established Diagnostic Pioneer: Over three decades of clinical excellence and trusted diagnostic services in Karachi and across Pakistan.
• ISO-Certified Quality: Strict adherence to international quality management systems and laboratory standards.
• Advanced Molecular Department: Equipped with state-of-the-art GeneXpert platforms for precise and rapid molecular testing.
• Expert Supervision: All molecular assays are supervised and reported by highly experienced consultant pathologists and microbiologists.
• Extensive Collection Network: Conveniently located collection centers across Karachi, making sample drop-off easy and accessible.
• Secure Digital Access: Instant report retrieval via a user-friendly online portal, mobile app, and automated SMS alerts.
• Rigorous Quality Control: Participation in external quality assurance programs to ensure the highest level of diagnostic accuracy.
• Compassionate Patient Care: Dedicated staff providing professional, patient-focused care in a comfortable and clean environment.